# Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent

> **NCT00589732** · PHASE4 · COMPLETED · sponsor: **Seung-Jung Park** · enrollment: 220 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Valsartan

## Key facts

- **NCT ID:** NCT00589732
- **Lead sponsor:** Seung-Jung Park
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 220 (ACTUAL)
- **Last updated:** 2012-08-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00589732

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00589732, "Valsartan for Suppression of Plaque Volume and Restenosis After Drug-Eluting Stent". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00589732. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*